approach to shock

SHOCK

Definition

Shock is acute circulatory failure resulting in inadequate oxygen delivery (DO₂) relative to tissue oxygen demand (VO₂), leading to cellular dysoxia, organ dysfunction, and, if untreated, death.

The key concept is inadequate tissue perfusion, not simply low blood pressure.

Why Shock Is Difficult to Define

Historically, shock was equated with hypotension. But hypotension is a late manifestation and neither necessary nor sufficient for the diagnosis.

Examples:

• Septic patients may have a MAP of 75 mmHg but severe hyperlactatemia and tissue hypoxia.
• Patients with chronic hypertension may develop cerebral or renal hypoperfusion at MAPs that are considered “normal.”
• Young trauma patients often maintain blood pressure until significant blood volume has been lost through sympathetic compensation.
• It can even presents with normal blood pressure and an increased cardiac output.

Pathophysiology

Shock develops whenever oxygen delivery fails to meet tissue metabolic requirements.

DO₂ < VO₂ → Tissue hypoxia → Anaerobic metabolism → Lactate generation → Cellular dysfunction → Organ failure

Where:

DO₂ = Cardiac Output × Arterial Oxygen Content (CaO₂)

Where:

• Cardiac Output = Heart Rate × Stroke Volume
• CaO₂ depends primarily on hemoglobin concentration and arterial oxygen saturation.

Consequently, shock may result from:

• Reduced cardiac output
• Severe anemia
• Profound hypoxemia
• A combination of these factors

The Four Determinants of Oxygen Delivery-A defect in any one of these can precipitate shock.

Macrocirculation vs Microcirculation

Correction of systemic hemodynamics does not guarantee restoration of tissue perfusion.

Patients may normalize their blood pressure while remaining in microcirculatory shock, particularly in sepsis.

Etiology

Many critically ill patients have mixed shock, involving more than one component simultaneously (e.g., septic cardiomyopathy with vasoplegia and hypovolemia).

Clinical Features

“Shock is a state of inadequate tissue perfusion—not a blood pressure.”Normal blood pressure does not exclude shock, and hypotension does not always indicate shock.

One of the biggest mistakes in critical care is waiting for hypotension before diagnosing shock. By the time blood pressure falls, 30–40% of circulating volume may already be lost, compensatory mechanisms(Sympathetic activation,RAAS activation,ADH release)may be exhausted, and organ injury may already be underway.

No single parameter—BP, lactate, CRT, ScvO₂, or urine output—can diagnose or exclude shock in isolation.

The most accurate assessment comes from integrating serial trends across multiple domains:

• Clinical examination
• Hemodynamics
• Laboratory markers
• Point-of-care ultrasound

Clinical Recognition of Shock

1. General Appearance

Look for:

• Anxiety or agitation—Restlessness
• Reduced responsiveness—Lethargy
• Toxic appearance
• Cyanosis—Diaphoresis—Respiratory distress

2. Mental Status

• Changes Suggesting Cerebral Hypoperfusion—Anxiety,Agitation,Confusion,Somnolence,Coma
• Always exclude alternative causes such as hypoglycemia, stroke, intoxication, or sedative medications.

3. Heart Rate

Tachycardia is often the earliest compensatory response.

Causes of Tachycardia in Shock

• Sympathetic activation
• Pain
• Fever
• Hypovolemia
• Reduced stroke volume
• Catecholamine administration

However, absence of tachycardia does not exclude shock.

Relative Bradycardia May Occur In:

• β-blocker therapy
• Calcium channel blocker therapy
• Complete heart block
• Neurogenic shock
• Advanced age
• Severe hyperkalemia
• Terminal shock

Clinical context is therefore essential.

4. Shock Index (SI)

The Shock Index is a simple bedside marker of hemodynamic compromise.

Shock Index = Heart Rate ÷ Systolic Blood Pressure

Limitations

• Less reliable in atrial fibrillation.
• Altered by β-blockers, pacemakers, and athletic conditioning.
• Does not identify the cause of shock.

Modified Shock Index (MSI)

The Modified Shock Index incorporates MAP instead of SBP.

MSI = HR ÷ MAP

This may correlate better with adverse outcomes in some critically ill populations because MAP more closely reflects organ perfusion pressure.

5. Pulse Pressure

Pulse Pressure = SBP − DBP

Pulse pressure provides insight into stroke volume and vascular tone.

A narrowing pulse pressure may precede hypotension in hemorrhagic shock.

6. Skin Temperature

Cold extremities generally indicate low cardiac output or intense vasoconstriction, whereas warm extremities suggest vasodilation.

7. Capillary Refill Time (CRT)

Capillary refill is assessed by compressing the distal finger for approximately 5 seconds, then measuring the time required for normal color to return.

Interpretation

The ANDROMEDA-SHOCK trial demonstrated that a resuscitation strategy guided by CRT was at least as effective as lactate-guided resuscitation and may reduce unnecessary fluid administration in septic shock.

Limitations

• Influenced by ambient temperature.
• Less reliable in severe peripheral vascular disease.
• May be difficult to interpret in darkly pigmented skin.

8. Mottling

Mottling is a patchy violaceous discoloration caused by heterogeneous cutaneous perfusion.

It usually begins around the knees and progresses proximally as shock worsens.

Clinical Significance

• Marker of severe vasoconstriction 
• implying that the patient would benefit from an increase in cardiac output (e.g. an inotrope) – not additional exogenous vasoconstrictors.

Mottling Score

Higher scores are associated with increased mortality.

9. Peripheral Perfusion Index (PPI)

The Peripheral Perfusion Index (PPI) is derived from the pulse oximeter waveform and reflects the ratio of pulsatile to non-pulsatile blood flow.

Interpretation

10. Urine Output

The kidney is highly sensitive to changes in renal perfusion.

Remember that oliguria may also result from intrinsic renal disease or urinary tract obstruction.

11. Respiratory Findings

Tachypnea is one of the earliest signs of shock and often reflects compensation for metabolic acidosis.

Possible mechanisms include:

• Lactic acidosis
• Pulmonary edema
• Acute respiratory distress syndrome (ARDS)
• Pulmonary embolism
• Pneumonia
• Pain or anxiety

The development of respiratory fatigue or rising PaCO₂ suggests impending ventilatory failure.

12. Lactate

Lactate is a marker of metabolic stress, not simply anaerobic metabolism.

Mechanisms of Hyperlactatemia

• Tissue hypoxia and anaerobic glycolysis
• β₂-adrenergic stimulation (e.g., sepsis, epinephrine)
• Impaired hepatic clearance
• Mitochondrial dysfunction
• Seizures
• Strenuous exercise
• Certain drugs (e.g., metformin-associated lactic acidosis in susceptible patients)

Lactate Clearance

A falling lactate level generally suggests improving tissue perfusion or reduced metabolic stress, whereas persistent or rising lactate should prompt reassessment of the diagnosis and resuscitation strategy.

Important: A normal lactate does not exclude shock, particularly in early presentations or localized hypoperfusion.

13.Base Deficit

Base deficit reflects the magnitude of metabolic acidosis.

Increasing base deficit may indicate:

• Progressive tissue hypoperfusion
• Hemorrhage
• Severe sepsis
• Ongoing shock

Serial measurements are more informative than isolated values.

14. Venous Oxygen Saturation (ScvO₂ and SvO₂)

Mixed venous (SvO₂) and central venous (ScvO₂) oxygen saturation estimate the balance between oxygen delivery and consumption.

A high ScvO₂ in septic shock should not be interpreted as reassuring; it may reflect failure of tissues to extract oxygen.

15. Venous-to-Arterial CO₂ Difference (P(v-a)CO₂ Gap)

The venous-to-arterial CO₂ gap can provide insight into blood flow relative to metabolic demand.

When interpreted alongside ScvO₂, it may help distinguish whether oxygen delivery is truly adequate.

Classification of  Shock

While useful for teaching, this approach has an important limitation:

Real ICU patients rarely fit neatly into one category.

For example:

• Septic shock often causes vasoplegia + hypovolemia + septic cardiomyopathy.
• Trauma patients may have hemorrhage + tension pneumothorax + myocardial contusion.
• A patient with myocardial infarction may develop cardiogenic shock, aspiration pneumonia, and septic shocksimultaneously.

Normal Hemodynamic Parameters

Additional Normal Hemodynamic Values (Often Used in Shock)

Guideline-Based Indications for Pulmonary Artery Catheter (PAC/Swan-Ganz Catheter) in Shock

Routine PAC insertion is NOT recommended. Echocardiography is the first-line modality for evaluation of shock, and PAC should be reserved for selected patients in whom advanced hemodynamic data are expected to change management. 

1. Persistent shock despite initial resuscitation

2. Shock of complex or mixed etiology

Examples:

• Septic + cardiogenic shock
• Cardiogenic + hypovolemic shock
• Mixed distributive and obstructive shock

Reason

• To determine the dominant hemodynamic abnormality (preload, cardiac output, SVR, RV dysfunction) and guide fluids, vasopressors, and inotropes.

3. Cardiogenic shock requiring advanced hemodynamic assessment

Examples:

• Acute MI with shock—Severe LV failure
• Fulminant myocarditis—Mechanical complications of MI

Reason–Quantify cardiac output, filling pressures, SVR, and mixed venous oxygen saturation to optimize vasoactive therapy.

4. Cardiogenic shock receiving Mechanical Circulatory Support (MCS)

Examples:VA-ECMO/Impella/IABP/TandemHeart

Reason–Optimize filling pressures, cardiac output, ventricular unloading, and guide escalation or weaning of support.

5. Predominant Right Ventricular (RV) failure

Examples:

• Massive pulmonary embolism
• RV infarction
• Severe pulmonary hypertension
• Advanced RV dysfunction

Reason

• Measure:
• Pulmonary artery pressure (PAP)
• Pulmonary artery wedge pressure (PAWP)
• Cardiac output
• Pulmonary vascular resistance (PVR)
• Mixed venous oxygen saturation (SvO₂)

Investigations

• History taking-Cardiac history,Adrenal disease,Current medications, thyroid disease,History of venous thromboembolic disease,Chemotherapy,steroid use(Immunosuppression)

Laboratory Tests

ECG

Look immediately for STEMI,Arrhythmias,Hyperkalemia,RV infarction,Pericarditis

A 12-lead ECG should be obtained early in every undifferentiated shock patient, unless a more urgent life-saving intervention takes precedence.

Chest X-ray

Useful for pulmonary edema—pneumonia—pneumothorax—widened mediastinum—line position

POCUS

The RUSH (Rapid Ultrasound in Shock) protocol is commonly organized into three components:

Management

Initial Resuscitation (The “VIPS” Bundle)-V – Volume,I – Inotropes,P – Pressors,S – Specific therapy (Antibiotics, source control, steroids when indicated, reperfusion, surgery, etc.)

Beware: Intubation Can Worsen Shock

• Positive-pressure ventilation reduces venous return.
• Sedative drugs reduce sympathetic tone.
• Both may precipitate:severe hypotension,pulseless electrical activity,cardiac arrest
• particularly in RV failure,tamponade,massive PE,hypovolemia

Choice of Induction Agent

Arterial Line

• Radial arterial lines may underestimate blood pressure in severe vasoconstriction then use femoral or axillary arterial line

Vascular Access

Peripheral IV

• Start with Two large-bore (16–18 G) peripheral IVs whenever possible.

EJV

• Guidelines typically restrict long-term, continuous peripheral or EJV vasopressor use without a central line (e.g., beyond 24 to 72 hours) or at extremely high doses, to mitigate the risk of infiltration

Intraosseous Access

• If IV access cannot be rapidly established in a critically ill patient,IO access is appropriate.

Central Venous Catheter

Needed for

• prolonged vasopressors
• multiple infusions
• difficult access
• advanced monitoring

Do not delay vasopressors solely to obtain central access. Norepinephrine can be started through a well-functioning proximal peripheral IV with close monitoring while central access is being arranged.

Refractory Shock Management

1. Define & Optimize MAP Target

• Target MAP ≥65 mmHg for most adults.
• Individualize MAP based on chronic hypertension, cerebrovascular disease, ICP, aortic disease, pregnancy, and evidence of organ perfusion.
• Assess perfusion, not BP alone:
• Mental status
• Urine output (>0.5 mL/kg/hr)
• Capillary refill (<3 sec)
• Skin temperature/mottling
• Lactate clearance
• POCUS/hemodynamics
• If requiring very high norepinephrine (>1 μg/kg/min) solely to maintain MAP >65 mmHg:
• Consider permissive hypotension (MAP 55–60 mmHg) if end-organ perfusion is adequate to reduce vasopressor toxicity.

2. Review Medications & Eliminate Causes of Hypotension

Sedation

• Minimize excessive sedation.
• Reduce/stop:
• Propofol
• Dexmedetomidine
• Consider more hemodynamically stable agents:
• Ketamine infusion: 0.1–0.5 mg/kg/hr (analgosedation); higher doses if required.
• Intermittent benzodiazepines if appropriate.

Stop unnecessary hypotensive medications

• α-blockers (tamsulosin, prazosin)
• Nitrates
• ACE inhibitors/ARBs
• Calcium-channel blockers
• Excess β-blockade (unless specifically indicated)

3. Optimize Preload

Reassess volume status rather than giving repeated empiric fluids.

Evaluate fluid responsiveness

• Passive leg raise
• Stroke volume change
• Bedside echocardiography
• Dynamic indices (PPV/SVV)

Correct reversible causes of reduced venous return

• Excessive PEEP → reduce if oxygenation permits
• Auto-PEEP → treat aggressively
• Longer expiratory time
• Lower RR
• Bronchodilator
• Disconnect briefly if severe dynamic hyperinflation

Fluids

• Additional crystalloid only if fluid responsive.
• Stop fluids once preload is adequate or congestion develops.

4. Optimize Cardiac Function

If cardiac output remains low despite adequate preload: use Inotropes

Dobutamine

• Indication
• Low cardiac output
• Cardiogenic shock
• Septic shock with myocardial dysfunction
• Dose—2–20 μg/kg/min

Epinephrine

• Useful when:
• Bradycardia
• Severe LV dysfunction
• Mixed cardiogenic + vasodilatory shock
• “Epinephrine challenge”
• Start 2–4 μg/min
• Continue if MAP or cardiac output improves

5. Metabolic Optimization

Correct reversible physiologic abnormalities that reduce vasopressor responsiveness.

Temperature

• Hypothermia
• ↓ myocardial contractility
• ↓ catecholamine responsiveness
• Hyperthermia
• ↑ oxygen demand
• ↑ vasodilation
• Maintain normothermia.

Calcium

Hypocalcemia markedly impairs vascular tone and myocardial contraction.

Indications-Ionized calcium <0.9 mmol/L

Calcium chloride

• 1 g IV via Central line preferred

Calcium gluconate

• 2–3 g IV
• Safe peripherally

Repeat doses guided by ionized calcium.

Acid-base Optimization

Acidosis decreases catecholamine responsiveness.

Treat the underlying cause.

May require:

• Ventilator optimization
• Dialysis
• Sodium bicarbonate

Sodium bicarbonate

Consider only if:

• Severe metabolic acidosis
• pH <7.1
• Hyperkalemia
• Severe AKI
• Bicarbonate loss

Routine bicarbonate for lactic acidosis is not recommended.

Thiamine

May improve aerobic metabolism.

Indications

• Alcoholism
• Malnutrition
• Persistent hyperlactatemia
• Septic shock

Dose

• 200 mg IV every 12 hours
• Some use 500 mg IV q8h if deficiency strongly suspected.

Steroids

Increase vascular responsiveness.

Hydrocortisone

• Indications
• Septic shock requiring moderate/high-dose vasopressors
• Suspected adrenal insufficiency
• Dose
• 200 mg/day
• Continuous infusion or 50 mg IV every 6 hr

Thyroid Hormone

For myxedema coma causing vasopressor-refractory shock.

Treatment

• IV levothyroxine ± IV liothyronine (T3)
• Give hydrocortisone before thyroid hormone if adrenal insufficiency not excluded.

6. Vasopressor Optimization

Norepinephrine

• First-line vasopressor.
• No absolute maximum dose.

Note—midodrine should not be used for to hasten weaning off vasopressor infusions.

Vasopressin

• Second-line adjunct.when norepinephrine reaches approximately 0.25–0.5 µg/kg/min 
• Dose–0.03 U/min(fixed-dose adjunct, not titrated)
• Monitor—Digital ischemia,Mesenteric ischemia,Hyponatremia,Reduced cardiac output

Vasopressor weaning protocol

If the patient is receiving:

• Norepinephrine + Vasopressin (0.03 U/min)

Preferred sequence:

1. Reduce and stop norepinephrine first
2. Continue vasopressin at its fixed dose
3. Once norepinephrine has been discontinued (or is at a minimal dose) and the patient remains stable, stop vasopressin

Why?

• Vasopressin is not titrated and provides a stable non-catecholamine vasoconstrictor effect.
• Abrupt discontinuation of vasopressin may cause rebound hypotension because many patients with septic shock have relative vasopressin deficiency.
• Norepinephrine can be gradually titrated down while vasopressin “supports” vascular tone.

Angiotensin II

Potent vasoconstrictor acting via RAAS.

Indications

• Vasodilatory shock refractory to norepinephrine + vasopressin

Dose

• Start 20 ng/kg/min
• Titrate (usual 5–40 ng/kg/min)

Monitor

• Thromboembolism (requires DVT prophylaxis)

Methylene Blue

Inhibits nitric oxide synthase and guanylate cyclase.

Best for:

• Vasoplegic syndrome after cardiac surgery
• Catecholamine-resistant septic vasoplegia
• Drug-induced vasoplegia (ACEI/ARB overdose)
• Metformin poisoning
• methemoglobinemia

Dose

• 1–2 mg/kg IV over 20–30 min
• May repeat once after several hours or continue infusion 0.25–0.5 mg/kg/hr for refractory cases.

Contraindications

• G6PD deficiency
• Concomitant serotonergic drugs (risk of serotonin syndrome)
• Severe pulmonary hypertension (relative)
• Cardiogenic shock
• Hypovolemic shock
• Pregnancy 

Adverse effects

• Blue discoloration of skin/urine
• Hemolysis (G6PD)
• Serotonin syndrome

Hydroxocobalamin

Nitric oxide scavenger.

Useful for:

• Refractory vasoplegic shock
• Cardiac surgery vasoplegia
• Cyanide poisoning

Dose

• 5 g IV over 15 minutes
• May repeat once (total 10 g)

Adverse effects

• Dark red urine
• Interferes with laboratory assays
• Transient hypertension

contraindications

• Continuous renal replacement therapy:
• Pulmonary HTN?
• Acute kidney injury (relative).

7. Heart Rate Optimization

Optimize heart rate only if bradycardia is contributing to low cardiac output (especially HR <50 bpm or relative bradycardia in shock where HR is inappropriately low, e.g., <80–90 bpm).

Identify and treat reversible causes

• Hypoxia, hyperkalemia, hypothermia
• Myocardial ischemia/infarction
• Drug toxicity (β-blockers, calcium-channel blockers, digoxin, amiodarone)
• Increased vagal tone
• Hypothyroidism/myxedema

Pharmacologic therapy

• Atropine: 1 mg IV every 3–5 min (maximum 3 mg); first-line for symptomatic bradycardia but often ineffective in infranodal block or transplanted hearts.
• Isoproterenol: 1–20 μg/min IV infusion (or equivalent titration); useful for refractory bradycardia, post-transplant hearts, or temporary bridge to pacing.
• Glycopyrrolate: 0.1–0.2 mg IV every 4–6 hr; less CNS penetration than atropine, but limited role in unstable bradycardia.

Pacing

• Transcutaneous pacing: Immediate bridge in unstable bradycardia.
• Temporary transvenous pacing: If persistent symptomatic bradycardia/high-grade AV block; titrate HR (often 80–100 bpm, occasionally 100–120 bpm) to maximize cardiac output.
• Permanent pacemaker: For persistent conduction disease after electrophysiology evaluation.

Pearls

• In shock, relative bradycardia may markedly reduce cardiac output even with “normal” BP.
• Increasing paced rate may not improve output if it suppresses native AV conduction or reduces ventricular filling—assess response with BP, cardiac output, lactate, urine output, and POCUS.

8. Right Ventricular (RV) Optimization

Optimize RV preload, reduce RV afterload, improve RV contractility, and maintain coronary perfusion.

Reduce RV Afterload

• Correct hypoxia, hypercapnia, and acidosis.
• Avoid excessive PEEP and high mean airway pressures.
• Treat pulmonary embolism if present.
• Inhaled pulmonary vasodilators
• Inhaled epoprostenol: 20–50 ng/kg/min (commonly started at 50 ng/kg/min) and titrate.
• Inhaled nitric oxide: 5–20 ppm (up to 40 ppm if needed).
• These selectively reduce pulmonary vascular resistance with minimal systemic hypotension.

Optimize RV Preload

• Avoid both hypovolemia and RV overdistension.
• Use POCUS/hemodynamic monitoring to guide fluids.
• Diurese if RV volume overloaded.

Improve RV Contractility

• Dobutamine: 2–20 μg/kg/min.
• Milrinone: Consider if pulmonary hypertension or RV failure; use cautiously due to hypotension.

Maintain Systemic Pressure

• Norepinephrine is preferred to maintain coronary perfusion of the RV.
• Add vasopressin if needed to reduce norepinephrine requirements.

Escalation

• Consider VA-ECMO for refractory RV failure despite maximal medical therapy.

9.Consider Mechanical Circulatory Support

If shock persists despite optimal fluids, vasopressors, and inotropes:

• VA-ECMO
• Impella
• Intra-aortic balloon pump (selected patients)
• TandemHeart

Primarily for severe cardiogenic shock.

References

1. Kollef MH, Despotovic VN, Kraft BD, McDonald RK, Nguyen N, editors. The Washington Manual® of Critical Care. 4th ed. Philadelphia: Wolters Kluwer; 2025. 
2. Chawla R, Todi S, editors. ICU Protocols: A Step-wise Approach. 3rd ed. Singapore: Springer; 2025. 
3. Irwin RS, Lilly CM, Mayo PH, Rippe JM, editors. Irwin and Rippe’s Intensive Care Medicine. 9th ed. Philadelphia: Wolters Kluwer; 2024.
4. Bhattacharya PK, Chawla R, editors. ISCCM Textbook of Critical Care Medicine. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers; 2026
5. Farkas J. Shock & vasoactive medications. In: Internet Book of Critical Care (IBCC). EMCrit Project. Updated June 17, 2024. Available from: EMCrit Project – Shock & Vasoactive Medications. Accessed 2026 Jul 19